Stock to buy, 16 names set to surge as pandemic fears recede: Evercore - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

Business News News

Business Business Latest News,Business Business Headlines

A Wall Street bank breaks down why Pfizer and BioNTech's vaccine efficacy news means a faster return to normal — and shares the 16 stocks set to bounce back rapidly as soon as COVID panic recedes

are clearing a path to lower equity risk premium and a higher market, but investors still need to be cognizant of the headwinds that could emerge, according to DeBusschere.

Another hurdle towards a complete normalization of economic activities is safety data, which has been positive from the 45,000 people dosed so far. "In recent meetings done by CDC, they've mentioned a number in the proximity of 10 million people vaccinated per month, which is a lot of people," he said. "But 10 million per month means it's going to take several months to start to get to levels where you've vaccinated a good amount of the US... Presumably, they can ramp it up to 20 million per month at some point.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Of course a Wall Street bank would say that and ignore the facts - like how much if an impact COVID has had on company revenues and the economy over the past year....just wait for the market to drop HARD late December

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines